# A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378

> **NCT05741437** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 24 (actual)

## Conditions studied

- Type II Diabetes

## Interventions

- **DRUG:** CKD-378, QD, PO Drug: D745, D150, QD, PO

## Key facts

- **NCT ID:** NCT05741437
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-11
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-09-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05741437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05741437, "A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05741437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*